The Life Sciences industry, ranging from discovery of targets and leads, to development of new drugs, diagnostics and therapeutics, to the delivery of patient care is well-suited to take advantage of an On-Demand computing and storage model. Scientists and physicians increasingly employ High Performance Computing capabilities and assets directly or indirectly:
- Researchers across a range of disciplines seek to identify and validate targets and leads
- Clinicians work to match genome and phenome to proteome
- Clinical trials managers and regulators aim to reduce development cost and time and produce a flawless submission
- Payers and providers strive to match data to actionable, accurate, timely diagnoses to drive better patient outcomes at lower lifetime cost
As research, development and diagnostic environments have become increasingly digital, and with the increasing pace of experimentation, innovation and advance, it may not be economical for an individual entity to build HPC capacity to meet its peak demand. CERT’s Blue Gene on demand delivery of high performance computing helps Life Sciences constituents meet peak demands for HPC capacity, while providing a better way to manage capital and operating costs. Life Sciences constituents can achieve attractive price/performance for data-intensive applications and processing large data volumes.
CERT’s Blue Gene offers applications for the Life Sciences sector and the details can be found in the ‘Life Science Applications’ section. |
